COVAX Statement on WHO Emergency Use Listing for AstraZeneca/Oxford COVID-19 Vaccine
[ad_1] The Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance (Gavi) and the World Health Organization (WHO), as
Read more[ad_1] The Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance (Gavi) and the World Health Organization (WHO), as
Read more[ad_1] Significant advances to the diagnosis of tuberculosis (TB) and drug resistance in adults, adolescents and children are expected,
Read more[ad_1] WHO has launched its first SMART Guideline, a landmark effort to accelerate the availability and impact of WHO health
Read more[ad_1] Pakistan to Afghanistan Sudan to Egypt Afghanistan to Iran Côte D’Ivoire to Mali Benin to Nigeria Afghanistan to Pakistan
Read more[ad_1] At the halfway point in the World Health Organization and Director-General Tedros Adhanom Ghebreyesus’ 100-day challenge, a movement of
Read more[ad_1] The ACT Accelerator partnership welcomes over US$ 4.3 billion of new investments from the USA, Germany, the European Commission, Japan, and Canada to
Read more[ad_1] We extend our condolences to our Tanzanian sisters and brothers on the recent passing of a senior Tanzanian
Read more[ad_1] New programme makes compensation available to eligible individuals in 92 low- and middle-income countries without need to resort to
Read more[ad_1] Following the first global infodemiology conference held in July 2020, WHO and partners coordinated a joint call for papers with 5 academic journals representing different scientific fields, all related
Read more[ad_1] COVAX announces 600,000 doses of the AstraZeneca/Oxford vaccine licensed to Serum Institute of India have arrived in Accra, Ghana;
Read more